Skip to main content
Caplight Logo









Skye Biologics Holdings

Skye Biologics Holdings

Private
El Segundo, CaliforniaHealthcare & Life Scienceshttps://skyebiologics.com

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Skye Biologics Holdings operates in Healthcare & Life Sciences and is based in El Segundo, California. It was founded in 2010.

Skye Biologics Holdings is a biotechnology company that discovers and develops therapeutics from human biological material to treat degenerative diseases, damaged tissue, injuries, and trauma.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Skye Biologics Holdings Comparables

Compare Skye Biologics Holdings with similar companies based on industry and business-model similarity.

Skye Biologics Holdings comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tides Medical
89%
Amnio Technology
88%
BioStem Technologies Inc
87%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Skye Biologics Holdings Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Skye Biologics Holdings. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Chris Sharp

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 38% MoM, reaching 2.9K.

  • Jul 25, 2026

    Monthly visitors grew 134% MoM, reaching 2.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Skye Biologics Holdings Filings

Explore SEC and related filing metadata, where available.

Skye Biologics Holdings filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Skye Biologics Holdings's valuation, stock price, and market status.

Is Skye Biologics Holdings a public or private company?

Skye Biologics Holdings is a private company.

What is the current stock price of Skye Biologics Holdings?

Skye Biologics Holdings is a private company, so its shares have no public market price. Caplight tracks Skye Biologics Holdings's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Skye Biologics Holdings worth (valuation)?

Valuation information for Skye Biologics Holdings is not publicly available.

Can I buy Skye Biologics Holdings stock?

Skye Biologics Holdings shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Skye Biologics Holdings's last funding round?

Funding round information for Skye Biologics Holdings is not publicly available.

Who are the main investors in Skye Biologics Holdings?

Investor information for Skye Biologics Holdings is not publicly disclosed.

Will Skye Biologics Holdings IPO soon?

No public IPO plans have been announced for Skye Biologics Holdings.

How can I track Skye Biologics Holdings secondary market activity?

Caplight tracks bids, offers, and trades in Skye Biologics Holdings's shares on secondary markets.

Firmographic Details

HeadquartersEl Segundo, California
Employee Range46
Year Founded2010
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?